Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

PBYI

Puma Biotechnology (PBYI)

Puma Biotechnology Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:PBYI
DateTimeSourceHeadlineSymbolCompany
05/17/20243:43PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:PBYIPuma Biotechnology Inc
05/02/20243:05PMBusiness WirePuma Biotechnology Reports First Quarter Financial ResultsNASDAQ:PBYIPuma Biotechnology Inc
04/18/20243:15PMBusiness WirePuma Biotechnology to Host Conference Call to Discuss First Quarter 2024 Financial ResultsNASDAQ:PBYIPuma Biotechnology Inc
04/03/20244:30PMBusiness WirePuma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:PBYIPuma Biotechnology Inc
03/20/20247:30AMBusiness WirePuma Biotechnology Announces FDA Allowance to Proceed Under IND for Alisertib in HER2-Negative, Hormone Receptor-Positive Metastatic Breast CancerNASDAQ:PBYIPuma Biotechnology Inc
02/29/20243:16PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:PBYIPuma Biotechnology Inc
02/29/20243:05PMBusiness WirePuma Biotechnology Reports Fourth Quarter and Full Year 2023 Financial ResultsNASDAQ:PBYIPuma Biotechnology Inc
02/27/20245:30PMBusiness WirePuma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:PBYIPuma Biotechnology Inc
02/22/20243:10PMBusiness WirePuma Biotechnology to Participate in a Panel Discussion at TD Cowen’s 44th Annual Health Care ConferenceNASDAQ:PBYIPuma Biotechnology Inc
02/15/20243:10PMBusiness WirePuma Biotechnology to Host Conference Call to Discuss Fourth Quarter and Full Year 2023 Financial ResultsNASDAQ:PBYIPuma Biotechnology Inc
02/14/20245:03PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PBYIPuma Biotechnology Inc
02/14/20245:01PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PBYIPuma Biotechnology Inc
02/14/20245:00PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PBYIPuma Biotechnology Inc
02/14/20244:54PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PBYIPuma Biotechnology Inc
02/14/20247:19AMEdgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:PBYIPuma Biotechnology Inc
02/13/20247:30AMBusiness WirePuma Biotechnology Announces Initiation of ALISCA-Lung1 Phase II Trial of Alisertib in Small Cell Lung CancerNASDAQ:PBYIPuma Biotechnology Inc
02/06/20242:54PMEdgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:PBYIPuma Biotechnology Inc
01/18/20248:00AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:PBYIPuma Biotechnology Inc
01/11/20243:07PMBusiness WirePuma Biotechnology to Present at B. Riley Securities 4th Annual Oncology ConferenceNASDAQ:PBYIPuma Biotechnology Inc
01/10/20243:41PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PBYIPuma Biotechnology Inc
01/10/20243:38PMEdgar (US Regulatory)Form 144/A - Report of proposed sale of securities: [Amend]NASDAQ:PBYIPuma Biotechnology Inc
01/05/20246:03PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PBYIPuma Biotechnology Inc
01/05/20246:00PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PBYIPuma Biotechnology Inc
01/05/20245:49PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PBYIPuma Biotechnology Inc
01/05/20245:42PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PBYIPuma Biotechnology Inc
01/03/20248:40PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:PBYIPuma Biotechnology Inc
01/03/20248:39PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:PBYIPuma Biotechnology Inc
01/03/20248:35PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:PBYIPuma Biotechnology Inc
01/03/20248:34PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:PBYIPuma Biotechnology Inc
12/11/20237:30AMBusiness WirePuma Biotechnology Announces Phase II Clinical Trial Design for Alisertib in HER2-Negative, Hormone Receptor-Positive Metastatic Breast CancerNASDAQ:PBYIPuma Biotechnology Inc
 Showing the most relevant articles for your search:NASDAQ:PBYI